Invention Grant
- Patent Title: Viral vectors for treating neurogenic detrusor overactivity
-
Application No.: US16312867Application Date: 2017-06-23
-
Publication No.: US11414666B2Publication Date: 2022-08-16
- Inventor: François Giuliano , Alberto Epstein , Olivier Le Coz , Alejandro Aranda
- Applicant: UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES , ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
- Applicant Address: FR Versailles; FR Paris
- Assignee: UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES,ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
- Current Assignee: UNIVERSITE DE VERSAILLES-ST QUENTIN EN YVELINES,ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS
- Current Assignee Address: FR Versailles; FR Paris
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: EP16305765.6 20160623
- International Application: PCT/EP2017/065587 WO 20170623
- International Announcement: WO2017/220800 WO 20171228
- Main IPC: A61K38/16
- IPC: A61K38/16 ; A61P13/00 ; A61K38/48 ; C12N15/869 ; C12N15/113 ; A61P13/06 ; A61K38/17 ; A61K38/45 ; A61K38/51 ; C12N15/86
Abstract:
The present invention provides a method and a pharmaceutical composition for the treatment of the NDO comprising the viral expression vector carrying a transcription cassette that harbors transgene(s) inhibiting/silencing neurotransmission or synaptic transmission of afferent neurons.
Public/Granted literature
- US20200071703A1 VIRAL VECTORS FOR TREATING NEUROGENIC DETRUSOR OVERACTIVITY Public/Granted day:2020-03-05
Information query
IPC分类:
